Breaking the Cycle of Pain With Clinical Pilates
NCT07929324, Not yet recruiting, Nanyang Technological University
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Breaking the Cycle of Pain With Clinical Pilates | ClinicalTrials.gov |
| NCT number | NCT07929324 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Enrollment | 60 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Nanyang Technological University | ClinicalTrials.gov |
| Conditions | Musculoskeletal Disorder | ClinicalTrials.gov |
| Interventions | Clinical Pilates | ClinicalTrials.gov |
| First posted | 2026-11-10 | ClinicalTrials.gov |
| Last updated | 2026-11-10 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Numeric Pain Rating Scale | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | Patients will report the level of pain associated with musculoskeletal disorders on a scale from 0 to 10. 0 indicates no pain, while 10 indicates severe pain. | ClinicalTrials.gov |
| Secondary | Patient-Specific Functional Scale | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | Patients identify 3 to 5 everyday activities they struggle with due to injury and score them on an 11-point scale from 0 (unable to perform) to 10 (able to perform at their prior level). | ClinicalTrials.gov |
| Secondary | Oswestry Disability Index | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | The Oswestry Disability Index (ODI) is a questionnaire used by clinicians to measure the extent to which low back pain affects a patient's daily functional activities. It assesses 10 categories, including pain intensity, lifting, walking, sleeping, and social life. The questionnaire consists of 10 sections, each scored from 0 to 5 points (maximum possible score of 50). This questionnaire is applicable only to patients with back conditions. | ClinicalTrials.gov |
| Secondary | Neck Disability Index | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | The Neck Disability Index (NDI) is the standard 10-item questionnaire used to assess how neck pain affects patients' daily life. Each of the 10 sections is scored on a 6-point scale from 0 (no disability) to 5 (worst possible limitation). It evaluates areas such as personal care, lifting, reading, headaches, work, and sleep. Each of the 10 sections is scored on a 6-point scale from 0 (no disability) to 5 (worst possible limitation). This questionnaire is applicable only to patients with neck conditions. | ClinicalTrials.gov |
| Secondary | Upper Extremity Functional Index | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | The Upper Extremity Functional Index (UEFI) is a 20-item patient-reported questionnaire that measures how upper-limb conditions (shoulder, wrist, or hand injuries) affect daily activities. Patients rate 20 specific activities on a 0-4 Likert scale. The total score ranges from 0 to 80. Higher scores (closer to 80) indicate better, unrestricted upper-limb function. Lower scores (closer to 0) indicate greater functional limitation or disability. This questionnaire is applicable only to patients with upper-limb conditions. | ClinicalTrials.gov |
| Secondary | Lower Extremity Functional Index | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | The Lower Extremity Functional Scale (LEFS) is a 20-item patient-reported questionnaire measuring how lower-limb problems affect daily activities. Patients rate 20 everyday physical activities on a 5-point scale (0 to 4) according to the difficulty they experience today due to their leg problem. Total scores range from 0 (extreme disability) to 80 (high function). Lower scores indicate greater functional impairment and disability, while higher scores indicate higher function and less disability. This questionnaire is applicable only to patients with lower-limb conditions. | ClinicalTrials.gov |
| Secondary | Short Form 12 | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | The Short Form 12 (SF-12) is a 12-item, patient-reported health questionnaire measuring an individual's overall health-related quality of life. It assesses eight health domains, including physical functioning, bodily pain, vitality, and mental health, and generates two standardised composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). | ClinicalTrials.gov |
| Secondary | Adverse events | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | The number of adverse events will be documented. | ClinicalTrials.gov |
| Secondary | Number of pain recurrences | Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups. | The number of pain recurrences will be documented. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)